As of 3:59pm ET
| +0.58 / +6.64%|
The 6 analysts offering 12-month price forecasts for PTC Therapeutics Inc have a median target of 12.50, with a high estimate of 25.00 and a low estimate of 10.00. The median estimate represents a +34.12% increase from the last price of 9.32.
The current consensus among 7 polled investment analysts is to Hold stock in PTC Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.